VISTA is markedly up-regulated on myeloid cells following neoadjuvant radiotherapy in HNSCC and OSCC, driving CD8+ T-cell exhaustion and independently predicting local relapse and distant metastasis. This evidence concerns the gene VSIR and head and neck squamous cell carcinoma.